Bharat Biotech's nasal vaccine showing good results in phase II trial: Chairman1 min read . Updated: 23 Oct 2021, 03:43 PM IST
- The adenoviral nasal vaccine BBV154 is first of a kind Covid-19 vaccine to undergo human trials in India.
Bharat Biotech has almost completed phase-2 trial for the nasal vaccine and it has shown good results, the pharma company's Chairman and MD said on Saturday.
Select your Category